Brookline, MA, United States of America

Ronald R Salem

This inventor holds 3 USPTO granted patents. Top assignees: New England Deaconess Hospital Corporation, Mallory Institute of Pathology Foundation. Active years: 1990-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald R Salem. Retrieved from https://idiyas.com/inventor/ronald-r-salem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1990-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Meet Ronald R. Salem: Innovator in Cancer Detection Technology

Introduction

Ronald R. Salem, an accomplished inventor based in Brookline, Massachusetts, has significantly contributed to the field of medical diagnostics through his innovative patents. With a focus on enhancing the detection and monitoring of colorectal carcinoma, he has dedicated his expertise to advancing health technologies.

Latest Patents

Among Ronald R. Salem's notable innovations is his recent patent titled "Marker for Colorectal Carcinoma and Methods of Detecting the Same." This invention identifies a glycoprotein marker with a molecular weight of approximately 160,000 daltons, which has proven essential for the detection, diagnosis, and monitoring of colorectal carcinoma, particularly the undifferentiated variety that has traditionally posed diagnostic challenges. The patented assay methods utilize an antibody that reacts specifically to this glycoprotein, offering a reliable means of screening patients for colorectal cancer. Furthermore, the assay can be incorporated into a kit designed for patient screening, enhancing the capabilities of medical professionals in identifying this critical health issue.

Career Highlights

Throughout his career, Ronald R. Salem has worked with reputable organizations that emphasize medical research and diagnostic advancements. He has significantly contributed to the New England Deaconess Hospital Corporation and the Mallory Institute of Pathology Foundation, both institutions noted for their dedication to innovative healthcare solutions. Salem's commitment to enhancing medical diagnostics is evident in the patents he has acquired, totaling three throughout his career.

Collaborations

In his journey of innovation, Ronald R. Salem has collaborated with prominent peers, including Peter Thomas and Glenn Steele. These collaborations highlight the importance of teamwork and collective expertise in advancing scientific research and medical technology.

Conclusion

Ronald R. Salem stands as a notable figure in the development of cancer detection technologies. His inventions, particularly focused on colorectal carcinoma, underscore the potential of innovative solutions in improving patient outcomes. As advancements in medical diagnostics continue to evolve, the contributions of inventors like Salem remain pivotal in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…